Clinical and pathological outcomes of nephrectomy/metastasectomy in patients with metastatic renal cell carcinoma after prior immune checkpoint inhibitor exposure

被引：0
|
作者：
Amaral, Paulo Siqueira
Beckermann, Katy
Hillis, Mikala
Schaffer, Kerry Roe
Ancell, Kristin Kathleen
Lambrecht, Morgan
Kaiser, Elizabeth
Rini, Brian I.
机构：
[1] Vandebilt Univ, Med Ctr, Nashville, TN USA
[2] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[3] Vanderbilt Univ, Dept Med, Med Ctr, Nashville, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16515
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Cachexia index in predicting outcomes among patients receiving immune checkpoint inhibitor treatment for metastatic renal cell carcinoma
    Aslan, Volkan
    Kilic, Atiye Cenay Karabork
    Sutcuoglu, Osman
    Eraslan, Emrah
    Bayrak, Ahmet
    Oksuzoglu, Berna
    Tahtaci, Gozde
    Ozdemir, Nuriye
    Uner, Aytug
    Gunel, Nazan
    Ozet, Ahmet
    Yazici, Ozan
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (11) : 494.e1 - 494.e10
  • [22] Efficacy of immune checkpoint inhibitor combination therapy prior to nephrectomy in advanced renal cell carcinoma: A retrospective pilot study
    Kiyota, Sho
    Yoshida, Takashi
    Nakamoto, Takahiro
    Jino, Eri
    Mishima, Takao
    Kinoshita, Hidefumi
    BJUI COMPASS, 2024, 5 (10): : 957 - 960
  • [23] A multicenter study assessing survival in patients with metastatic renal cell carcinoma receiving immune checkpoint inhibitor therapy with and without cytoreductive nephrectomy
    Gross, Evan E.
    Li, Mingjia
    Yin, Ming
    Orcutt, Delaney
    Hussey, Duncan
    Trott, Elliot
    Holt, Sarah K.
    Dwyer, Erin R.
    Kramer, Joel
    Oliva, Kaylee
    Gore, John L.
    Schade, George R.
    Lin, Daniel W.
    Tykodi, Scott S.
    Hall, Evan T.
    Thompson, John A.
    Parikh, Anish
    Yang, Yuanquan
    Collier, Katharine A.
    Miah, Abdul
    Mori-Vogt, Sherry
    Hinkley, Megan
    Mortazavi, Amir
    Monk, Paul
    Folefac, Edmund
    Clinton, Steven K.
    Psutka, Sarah P.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (01) : 51.e25 - 51.e31
  • [24] Re: Oncological Outcomes of Delayed Nephrectomy After Optimal Response to Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma Editorial Comment
    Laguna, M. Pilar
    Pignot, G.
    Thiery-Vuillemin, A.
    Albiges, L.
    JOURNAL OF UROLOGY, 2023, 210 (01): : 216 - 216
  • [25] Nephrectomy After Complete Response to Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma: A New Surgical Challenge?
    Pignot, Geraldine
    Thiery-Vuillemin, Antoine
    Walz, Jochen
    Lang, Herve
    Werle, Pierre
    Balssa, Lac
    Geoffrois, Lionnel
    Leblanc, Louis
    Albiges, Laurence
    di Nunno, Vincenzo
    Bensalah, Karim
    Ladoire, Sylvain
    Gravis, Gwenaelle
    Barthelemy, Philippe
    EUROPEAN UROLOGY, 2020, 77 (06) : 761 - 763
  • [26] A phase II trial of sitravatinib plus nivolumab after progression on prior immune checkpoint inhibitor (ICI) in patients with metastatic clear cell renal cell carcinoma (ccRCC)
    Dizman, Nazli
    Adra, Nabil
    Vaishampayan, Ulka N.
    Xiao, Lianchun
    Yuan, Ying
    Campbell, Matthew T.
    Gao, Jianjun
    Zurita, Amado J.
    Jonasch, Eric
    Tannir, Nizar M.
    Shah, Amishi Yogesh
    Msaouel, Pavlos
    Hahn, Andrew Warren
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [27] Pathologic response and surgical outcomes in patients undergoing nephrectomy after receipt of immune checkpoint inhibitors for renal cell carcinoma.
    Margulis, Vitaly
    Singla, Nirmish
    Elias, Roy
    Ghandour, Rashed
    Freifeld, Yuval N.
    Bowman, I. Alex
    Woldu, Solomon L.
    Gahan, Jeffrey
    Bagrodia, Aditya
    Brugarolas, James
    Hammers, Hans J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [28] RACIAL DIFFERENCES IN OUTCOMES FOR METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS MANAGED ON IMMUNE-CHECKPOINT INHIBITOR (ICI) THERAPY
    Olsen, T. Anders
    Martini, Dylan
    Goyal, Subir
    Liu, Yuan
    Evans, Sean
    Magod, Benjamin
    Brown, Jacqueline
    Yantorni, Lauren
    Russler, Greta
    Caulfield, Sarah
    Goldman, Jamie
    Nazha, Bassel
    Harris, Wayne
    Master, Viraj
    Kucuk, Omer
    Carthon, Bradley
    Bilen, Mehmet
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A133 - A133
  • [29] Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint Therapy
    Hahn, Andrew W.
    Surasi, Devaki Shilpa
    Viscuse, Paul V.
    Bathala, Tharakeswara K.
    Wiele, Andrew J.
    Campbell, Matthew T.
    Zurita, Amado J.
    Shah, Amishi Y.
    Jonasch, Eric
    Gao, Jianjun
    Goswami, Sangeeta
    Alhalabi, Omar
    Rao, Priya
    Sircar, Kanishka
    Tannir, Nizar M.
    Msaouel, Pavlos
    ONCOLOGIST, 2023, : 392 - 399
  • [30] Nephrectomy after complete response to immune checkpoint inhibitors for Metastatic Renal Cell Carcinoma (mRCC): A surgical challenge allowing favorable oncological outcomes
    Pignot, G.
    Thiery-Vuillemin, A.
    Walz, J.
    Lang, H.
    Balssa, L.
    Geoffrois, L.
    Leblanc, L.
    Albiges, L.
    Bensalah, K.
    Ladoire, S.
    Bigot, P.
    Ingels, A.
    Saldana, C.
    Roubaud, G.
    Piechaud, T.
    Cassuto, O.
    Klifa, D.
    Parier, B.
    Bernhard, J. C.
    Malouf, G.
    Gravis, G.
    Barthelemy, P.
    EUROPEAN UROLOGY, 2021, 79 : S892 - S893
12345